Digital Landscape: Inflammatory Bowel Disease

Publisher Name :
Date: 06-Sep-2018
No. of pages: 159

Digital Landscape: Inflammatory Bowel Disease

Summary

The Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn's disease and ulcerative colitis (UC).

Key Highlights

- US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly branded, unbranded and mobile app. Janssen was the most active competitor in the branded and social media spaces in 2017. Branded activity also seen from pipeline and biosimilar competitors. No IBD-specific mobile apps detected from pharma. Opportunity exists for a well-integrated unbranded campaign to support patients, linked to social media and a mobile app.

- US HCPs: Good support available for US HCPs in the IBD branded space, with Stelara and Humira activity detected from Janssen and AbbVie in 2017, respectively. Unbranded and mobile app landscapes are sparse. Opportunities may exist to develop or sponsor content with trusted non-pharma organizations; social media activity restricted to corporate accounts.

- EUCAN Patients: Good brand support for patients in Germany, the UK, and Canada, with IBD-specific activity detected from Takeda and Janssen in 2017. No multi-country unbranded from biologics manufacturers with Ferring providing the only example. Unbranded support is strongest in Germany overall, with new sites launched by Janssen and Pfizer in 2017. Social media support is weak overall; EUCAN IBD patients have access to good mobile app offerings, however none detected in Italy.

- EUCAN HCPs: The EUCAN HCP landscape is underdeveloped. Most branded activity limited to Germany or the UK with all new activity seen in the UK in 2017. The unbranded and mobile app landscapes are particularly sparse, and partnerships with non-pharma organizations may offer more effective opportunities to engage with and support HCPs.

Scope

- This report analyzes digital activities undertaken by pharma in support of therapies for disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn's disease and ulcerative colitis (UC).

- The report includes digital activities directed towards patients and/or HCPs, including branded websites, unbranded disease awareness initiatives, social media and mobile apps.

- The report is based on analysis conducted by a combination of GlobalData's digital and disease-specific teams. It also includes analysis of data licensed from third parties e.g. website traffic, search engine optimization (SEO), digital display advertising, mobile app downloads, and social media interaction.

- The geographic scope of the report is the United States, Canada and the 5EU (UK, Germany, France, Italy & Spain), with EUCAN used as an abbreviation for Europe and Canada throughout.

- This report covers the research period from January - December 2017.

Reasons to buy

- Our Digital Landscape report provides an analysis of pharma multichannel activity in the digital IBD space, and can assist our pharma clients derive value in a number of ways -

- Competitive Intelligence: Track and compare key competitor activity across channels and identify key trends in IBD

- Digital Strategy: Strengthen corporate digital excellence, learn from industry best practice, and identify opportunities for novel digital campaigns

- Support new brand launch: See best practice examples of pre- and post-launch digital activities, ascertain must-have digital assets for patient and HCP engagement, and assess potential gaps and opportunities for pipeline brands

- Business Development & Licensing: Assess topics and trends shaping digital health in IBD and beyond, and learn about key patient and physician online activities in IBD.

Digital Landscape: Inflammatory Bowel Disease

Table of Contents
Executive Summary
Recent Developments
Landscape & Analysis
US: Patient-directed Activities
US HCP-directed Activities
EUCAN Patient-directed Activities
EUCAN HCP-directed Activities
Methodology
  • Global Gastroparesis Drugs Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 99
    Gastroparesis also known as delayed gastric emptying, is a disorder that stops or slows the movement of food through the digestive tract. The idiopathic gastroparesis segment dominated the global gastroparesis drugs market during 2017 and the segment is expected to continue its dominance during the next few years as well. The market is witnessing the development of new and effective therapies for the symptomatic control of idiopathic gastroparesis, which will be one of the major factors r......
  • Global Gastrointestinal OTC Drugs Market Size, Status and Forecast 2019-2025
    Published: 18-Jan-2019        Price: US 3900 Onwards        Pages: 90
    Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. In 2018, the global Gastrointestinal OTC Drugs market size was xx million US$ and it is e......
  • Anti Peptic Ulcer Drugs Markets in China
    Published: 17-Jan-2019        Price: US 4000 Onwards        Pages: 211
    China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity,......
  • Anti Peptic Ulcer Drugs Companies in China
    Published: 17-Jan-2019        Price: US 1800 Onwards        Pages: 54
    This study focuses on China's Anti Peptic Ulcer Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......
  • Anti Peptic Ulcer Drugs Industry Forecasts - China Focus
    Published: 17-Jan-2019        Price: US 1800 Onwards        Pages: 107
    This study focuses on China's Anti Peptic Ulcer Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......
  • Global Exocrine Pancreatic Insufficiency Market Size, Status and Forecast 2019-2025
    Published: 17-Jan-2019        Price: US 3900 Onwards        Pages: 95
    Exocrine pancreatic insufficiency (EPI) is an inability of proper digestion of food owing to insufficient levels of digestive enzymes from pancreas. EPI is commonly found in humans affected with Shwachman-Diamond Syndrome and cystic fibrosis. EPI is triggered by the progressive loss of pancreatic cells, which generates the digestive enzymes. EPI disturbs the normal growth, life expectancy and immune response. Diarrhoea, Steatorrhea, fatigue and weight loss are the key symptoms of EPI.......
  • Helicobacter Pylori Infections - Market Insight, Epidemiology and Market Forecast - 2028
    Published: 15-Jan-2019        Price: US 6250 Onwards        Pages: 100
    DelveInsight's "Helicobacter Pylori Infections - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Helicobacter Pylori Infections epidemiology and market outlook for the 7MM. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Helicobacter Pylori Infections Understanding and Treatment Algorithm The mar......
  • Short Bowel Syndrome - Epidemiology Forecast to 2028
    Published: 15-Jan-2019        Price: US 3250 Onwards        Pages: 50
    DelveInsight's "Short Bowel Syndrome - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Short Bowel Syndrome epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. Markets Covered - United States - EU5 (Germany, France, Italy, Spain, and the United Kingdom) - Japan Study Period: 2016-2028 Short Bowel Syndrome Epidemiology The epidemiology......
  • Exocrine Pancreatic Insufficiency - Pipeline Insight, 2019
    Published: 15-Jan-2019        Price: US 1250 Onwards        Pages: 50
    "Exocrine Pancreatic Insufficiency - Pipeline Insight, 2019" report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Exocrine Pancreatic Insufficiency development. The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule ty......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs